04:50 AM EST, 11/08/2024 (MT Newswires) -- Travere Therapeutics ( TVTX ) said late Thursday it priced an underwritten public offering of about 7.8 million shares of its common stock at $16 each for expected gross proceeds of $125 million.

The company granted the underwriters a 30-day option to buy up to an additional about 1.2 million shares. The offering is expected to close on Nov. 12.

Price: 17.25, Change: -0.41, Percent Change: -2.32